Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

May 31, 2013

Conditions
Colon Carcinoma
Interventions
DRUG

Dipeptide Alanyl-Glutamine

Intravenous supplementation of the dipeptide alanyl-glutamine is started 24 hours prior to surgery (dosage glutamine: 0,5 g/kg/day, and continued 24 hours postoperatively.

DRUG

Placebo

Intravenous and enteral supplementation of placebo is started 24 hours prior to surgery and continued 24 hours postoperatively.

DRUG

Dipeptide Alanyl-Glutamine

Enteral supplementation of the dipeptide alanyl-glutamine is started 24 hours prior to surgery (dosage glutamine: 0,5 g/kg/day, and continued 24 hours postoperatively.

Trial Locations (1)

1815 JD

RECRUITING

Medical Center Alkmaar, Alkmaar

Sponsors
All Listed Sponsors
lead

Medical Center Alkmaar

OTHER